We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
KeyCorp
KEY
$24.3B
| $6.92M | 0.02% |
341,727
-26,574
| -7% | -$501K |
|
427
Cooper Companies
COO
$13.7B
| $6.91M | 0.02% |
85,960
-5,932
| -6% | -$447K |
|
428
Lincoln National
LNC
$7.91B
| $6.85M | 0.02% |
116,140
-4,310
| -4% | -$254K |
|
429
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
| $6.82M | 0.02% |
1,221,690
-47,360
| -4% | -$252K |
|
430
ResMed
RMD
$28.3B
| $6.81M | 0.02% |
43,957
-416
| -0.9% | -$60K |
|
431
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $6.81M | 0.02% |
61,789
+9,919
| +19% | +$1.11M |
|
432
MarketAxess Holdings
MKTX
$4.15B
| $6.81M | 0.02% |
17,962
+713
| +4% | +$262K |
|
433
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
| $6.78M | 0.02% |
220,902
-4,584
| -2% | -$135K |
|
434
Constellation Brands
STZ
$22.2B
| $6.77M | 0.02% |
35,680
-3,350
| -9% | -$633K |
|
435
GSK
GSK
$103B
| $6.69M | 0.02% |
113,825
+10,823
| +11% | +$602K |
|
436
DexCom
DXCM
$27.6B
| $6.68M | 0.02% |
122,268
+2,220
| +2% | +$105K |
|
437
Schwab US Large- Cap ETF
SCHX
$70.9B
| $6.67M | 0.02% |
520,662
-9,396
| -2% | -$115K |
|
438
Ameren
AEE
$31.5B
| $6.66M | 0.02% |
86,765
-18,381
| -17% | -$1.4M |
|
439
First Financial Bancorp
FFBC
$3.55B
| $6.61M | 0.02% |
259,768
-608
| -0.2% | -$14.8K |
|
440
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
| $6.59M | 0.02% |
82,028
-7,988
| -9% | -$619K |
|
441
Canadian Natural Resources
CNQ
$96.9B
| $6.59M | 0.02% |
415,864
-17,512
| -4% | -$238K |
|
442
Steris
STE
$20.9B
| $6.58M | 0.02% |
43,179
-4,807
| -10% | -$705K |
|
443
Vanguard Mid-Cap Value ETF
VOE
$23.7B
| $6.57M | 0.02% |
55,084
+17,869
| +48% | +$2.06M |
|
444
Mitsubishi UFJ Financial
MUFG
$258B
| $6.56M | 0.02% |
1,207,270
-38,035
| -3% | -$201K |
|
445
Corning
GLW
$126B
| $6.55M | 0.02% |
224,969
-59,130
| -21% | -$1.72M |
|
446
Tesla
TSLA
$1.24T
| $6.53M | 0.02% |
234,180
+7,935
| +4% | +$172K |
|
447
Shopify
SHOP
$148B
| $6.53M | 0.02% |
164,180
+11,740
| +8% | +$397K |
|
448
Sabesp
SBS
$19.7B
| $6.51M | 0.02% |
2,229,201
-485,517
| -18% | -$1.25M |
|
449
Exelon
EXC
$48.6B
| $6.49M | 0.02% |
199,599
+11,162
| +6% | +$361K |
|
450
Philips
PHG
$25.4B
| $6.49M | 0.02% |
167,297
+33,249
| +25% | +$1.2M |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.